Measurement of serum carbonic anhydrase IX (CA9) protein levels in metastatic ccRCC patients revealed significantly decreased OS among patients with higher CA9 serum concentrations [12]. This evidence concerns the gene CA9 and nonpapillary renal cell carcinoma.